Related Experiment Videos
Thrombolytic therapy for myocardial infarction. Treatment introduced in northern Ontario
Insights
Most remote Canadian hospitals, particularly in northern Ontario, are not fully equipped to provide intravenous thrombolytic therapy for acute myocardial infarctions (MI). This review examines streptokinase use in family physician-run settings.
Area of Science:
- Cardiology
- Public Health
- Rural Medicine
Background:
- Most acute myocardial infarction (MI) patients in remote Canadian regions are managed by general practitioners.
- Intravenous thrombolytic therapy for MI is standard in hospitals with cardiology services.
- Access to advanced cardiac care varies significantly in remote areas.
Purpose of the Study:
- To assess the availability of intravenous thrombolytic therapy in northern Ontario general hospitals.
- To review the utilization of streptokinase in a family physician-led hospital setting.
Main Methods:
- A survey was conducted among northern Ontario general hospitals regarding thrombolytic therapy.
- Case review of streptokinase administration in a family physician-run hospital.
Main Results:
- 32 out of 45 surveyed northern Ontario general hospitals reported offering IV thrombolytic therapy.
- The study specifically reviewed streptokinase use in one family physician-run hospital.
Conclusions:
- Availability of critical MI treatments like IV thrombolysis remains a challenge in remote Canadian healthcare settings.
- Further investigation into the practical application and outcomes of thrombolytic therapy in primary care settings is warranted.
Abstract:
In remote regions of Canada, most patients with acute myocardial infarctions (MI) are treated by general practitioners. In hospitals served by cardiologists, intravenous thrombolytic therapy for MI is now routinely available. In a survey of northern Ontario general hospitals, 32 of 45 offered IV thrombolytic therapy. The use of streptokinase in one family physician-run hospital was also reviewed.